|
|
 |
|
|
NOAH Supports Neoadjuvant Herceptin, but Timing Elusive
ISSUE: JUNE, 2009
San Antonio—Adding trastuzumab (Herceptin, Genentech) to neoadjuvant chemotherapy extends event-free survival (EFS) in women with locally advanced HER2-positive breast cancer, according to final results of the Phase III NOAH (NeOAdjuvant Herceptin) trial.
read more |
New Cold Storage Strategies Help Protect High-Cost Drugs
ISSUE: JUNE, 2009
New methods of storing high-cost biologics and medications that require refrigeration can help ensure the integrity and accurate dispensing of these products.
read more |
IVIG and Aseptic Meningitis
ISSUE: JUNE, 2009
Jerry Siegel, PharmD, FASHP discusses this rare but serious side effect of immune globulin therapy.
read more |
Load Up With a Statin Before Elective PCI
Study shows strategy can protect the heart.
ISSUE: JUNE, 2009
Orlando, Fla.—Giving patients one or two loading doses of atorvastatin on the day before elective percutaneous coronary intervention (PCI) has a cardioprotective effect, whether or not the patients were receiving maintenance statin therapy, according to two studies from Italy presented at the American College of Cardiology 2009 annual meeting.
read more |
|
 |
|